Skip to main content

Table 3 Patient summary

From: AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

Dialysis membrane

AN69ST

PS

P value

Age (years)

69.8 ± 11.4

67.4 ± 19.6

N.S.

Sex (male:female)

13:6

6:5

N.S.

Body weight

58.2 ± 14.6

62.3 ± 16.9

N.S.

SOFA

11.1 ± 4.0

9.5 ± 4.4

N.S.

APACHE II

27.6 ± 10.0

26.9 ± 10.4

N.S.

Mortality

6/19 (32%)

3/11 (27%)

N.S.

Sepsis

13/19 (68%)

3/11 (27%)

0.03

QB (mL/min)

95.9 ± 8.9

95.1 ± 15.4

N.S.

QD (mL/h)

934.8 ± 329.6

1422.4 ± 602.5

<0.01

QS (mL/h)

517.7 ± 152.5

602.6 ± 312.8

N.S.

QF (mL/h)

1471.7 ± 414.7

1852.4 ± 662.2

<0.01

  1. Data are the mean and standard deviation or number. For intergroup testing, the Mann-Whitney U test or the χ 2 test was performed at suitable locations. AN69ST polyacrylonitrile (surface treated), PS polysulfone, N.S. not significant, SOFA Sequential Organ Failure Assessment, APACHE II Acute Physiology and Chronic Health Evaluation II score, QB blood pump flow rate, QD dialysate pump flow rate, QF filtration pump flow rate, QS substitution fluid pump flow rate